Diabetes

Incidence of diabetes continues to grow rapidly worldwide, making the metabolic disease a key focus for clinical trials taking place in Oxford.

Diabetes trials in Oxford build on a fine history, and span the entire spectrum: from first-in-man translational research studies, through large-scale international phase III and IV trials, to primary health care research investigating optimal methods of treatment and monitoring at the patient level. With a wide network of collaborators, both within Oxford and as far afield as China and the US, our capabilities in diabetes trials are truly world-leading.

 

At a glance